TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery
| Status: | Recruiting |
|---|---|
| Conditions: | Colorectal Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 90 |
| Updated: | 2/7/2019 |
| Start Date: | March 1, 2017 |
| End Date: | December 16, 2019 |
| Contact: | Jon Zhou, MD |
| Email: | jonzhou@ucdavis.edu |
| Phone: | 916-734-5028 |
Transversus Abdominus Plane (TAP) Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery: A Prospective Randomized Control Trial
This is a prospective randomized study designed to compare the pain control from a single
shot of liposomal bupivacaine (Exparel) against transversus abominus plane (TAP) catheters
with ropivicaine bolus in patients undergoing elective colorectal surgery.
shot of liposomal bupivacaine (Exparel) against transversus abominus plane (TAP) catheters
with ropivicaine bolus in patients undergoing elective colorectal surgery.
At UC Davis, it is standard practice to place TAP blocks with catheters for adult colorectal
surgery patients for perioperative pain control. This practice, however, is resource
intensive, adds the risk of catheter-related complications, and adds increased burden to
patients by requiring them to be tethered to 2 catheters.
An alternative TAP can be performed using a single shot of liposomal bupivacaine (Exparel),
an extended release local anesthetic that is FDA-approved for surgical plane infiltration
including TAP blocks.
With this prospective study, we seek to improve patient care at UC Davis and educate other
institutions through the use of concrete data comparing these 2 treatment options.
surgery patients for perioperative pain control. This practice, however, is resource
intensive, adds the risk of catheter-related complications, and adds increased burden to
patients by requiring them to be tethered to 2 catheters.
An alternative TAP can be performed using a single shot of liposomal bupivacaine (Exparel),
an extended release local anesthetic that is FDA-approved for surgical plane infiltration
including TAP blocks.
With this prospective study, we seek to improve patient care at UC Davis and educate other
institutions through the use of concrete data comparing these 2 treatment options.
Inclusion Criteria:
- Patients scheduled for elective colorectal surgery with Dr. Linda Farkas
Exclusion Criteria:
- Patients under 18 years of age
- Patient over 90 years of age
- Pregnancy
- Prisoners
- Patients unable to provide consent
- Patients on systemic anticoagulation therapy
- Patients with an allergy to local anesthetics
We found this trial at
1
site
Click here to add this to my saved trials
